Clinical trial
An Open Label, Prospective, Randomized, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of TachoSil® Versus Surgicel™ Original (Oxidized Regenerated Cellulose) as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery.
NCT06664775 is registered in ClinicalTrials.gov with Corza Medical GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label, Prospective, Randomized, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of TachoSil® Versus Surgicel™ Original (Oxidized Regenerated Cellulose) as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery.
- Lead sponsor
- Corza Medical GmbH
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- April 2, 2025
- Completion date
- December 31, 2026
- Enrollment
- 116 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.